아위로부터 분리된 세스키테르펜 화합물을 포함하는 항암제 조성물
    1.
    发明公开
    아위로부터 분리된 세스키테르펜 화합물을 포함하는 항암제 조성물 失效
    含有由ASAFOETIDA分离的SESQUITERPENE化合物的反应物组合物

    公开(公告)号:KR1020020029210A

    公开(公告)日:2002-04-18

    申请号:KR1020000060039

    申请日:2000-10-12

    Abstract: PURPOSE: An anticancer composition containing sesquiterpene compounds separated from asafoetida exhibiting an excellent cell proliferation inhibiting effect against a human cancer cell line is provided which can be used as a preventive and therapeutic agent against various malignant tumors such as lung cancer, ovarian cancer, melanoma, central nervous tumor colon cancer or the like. CONSTITUTION: This anticancer composition contains sesquiterpene compounds separated from asafoetida, namely one selected from the group consisting of galvanic acid, karatavicinol, umbelliprenin, farnesiferol B, farnesiferol C and mixtures thereof separated from asafoetida as an effective agent and a pharmaceutically acceptable carrier.

    Abstract translation: 目的:提供一种抗癌组合物,其含有对于表达对人癌细胞系具有优异的细胞增殖抑制作用的从三萜烯分离的倍半萜化合物,其可用作针对各种恶性肿瘤如肺癌,卵巢癌,黑素瘤, 中枢神经肿瘤结肠癌等。 构成:该抗癌剂组合物含有从沙蒿中分离出的倍半萜化合物,即选自起始酸,卡拉他宁,伞形螺蛋白,法尼塞醇B,法呢松酚C及其作为有效药剂分离的混合物的一种和药学上可接受的载体。

Patent Agency Ranking